N/A N=106 Randomized Triple-blind Other

QL vs PENG for Analgesia After Hip Arthroplasty

Block · Hip Replacement · Postoperative Pain

Bottom Line

View on ClinicalTrials.gov: NCT05710107 ↗

Enrolled (actual)

106

Serious AEs

0.0%

Results posted

Dec 2024

Primary outcome: Primary: Postoperative Cumulative Opioid Consumption — 12.7; 9.9; 29.4; 23.2 morphine milligram equivalents

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: PENG + LFC Block (Other); QL Block (Other)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Medical University of South Carolina
Primary completion: Nov 2023

Outcome Measures

Outcome	Result	p-value
PRIMARY Postoperative Cumulative Opioid Consumption	12.7; 9.9; 29.4; 23.2; 46.1; 36.4	—
SECONDARY Average Postoperative Pain Score	33.2; 29.5; 47.2; 43.5; 48.7; 45.1	—

Summary

This study will consist of patients 18 years and older who are undergoing elective hip replacement with planned same day discharge. The patients will be randomized to receive a PENG+LFC or QL block prior to undergoing the surgery to help with postoperative pain control. The primary goal will be assessing postoperative opioid use during the first 72 hours after surgery. Secondary outcomes will include postoperative pain scores from, 0-72 hours. Additional outcomes consist of time to first ambulation, functional and mobility outcomes, PACU duration, patient satisfaction and opioid related side effects.

Eligibility Criteria

Inclusion Criteria

age greater than or equal to 18 years of age
undergoing elective hip arthroplasty with planned same day discharge

Exclusion Criteria

local anesthetic allergy
subjects with a weight less than 40kg
subjects that are unable or choose not to give informed consent
Known preoperative substance abuse

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05710107). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.